## Abstract ## BACKGROUND Vascular endothelial growth factor C (VEGFβC) plays an important role in lymphangiogenesis and activates VEGF receptor 3 (VEGFRβ3). By contrast, lymphatic spread is an important prognostic factor in patients with nonsmall cell lung carcinoma (NSCLC). The objective of the
The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients
β Scribed by Daiki Masuya; Cheng-long Huang; Dage Liu; Kotaro Kameyama; Eiichi Hayashi; Akira Yamauchi; Shoji Kobayashi; Reiji Haba; Hiroyasu Yokomise
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 556 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the
histologic features on hematoxylin and eosin stained sections, and microvessel density and distribution using sections immunostained for factor VIII-related anti-1 Departments of Pathology, Beth Israel Deagen. In addition, in situ hybridization was performed on formalin fixed, paraffin coness Medica
## Abstract ## BACKGROUND Recently, the authors identified molecular signatures and pathways associated with nonsmall cell lung carcinoma histology and lung development. They hypothesized that genetic classifiers of histology would provide insight into lung tumorigenesis and would be associated wi
## Abstract Vascular endothelial growth factor (VEGF) expression has been suggested to correlate with intratumoral microvessel density, tumor advancement and prognosis in esophageal squamous cell carcinoma (ESCC). Previous studies have showed that disruption of cell cycle regulator p16 is related t
## Abstract ## BACKGROUND The authors measured circulating vascular endothelial growth factorβC (VEGFβC) and vascular endothelial growth factor (VEGF) levels in patients with primary nonsmall cell lung carcinoma and assessed its usefulness as a diagnostic tool for determining lymph node metastasis